Podcast - Biopharmaceutical Manufacturing in India: The Challenges - - BioPharm International

ADVERTISEMENT

Podcast - Biopharmaceutical Manufacturing in India: The Challenges




Ajit Mahadevan
Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young

Add this Podcast feed to your media player



Faced with economic pressures and budget constraints, biopharmaceutical companies are increasingly looking at outsourcing as a cost-effective alternative. In this interview, Ajit Mahadevan, Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young, discusses current trends and challenges of outsourcing biomanufacturing-related activities to India.

Click here to go to the main podcast page >>>


Related Links:
India Today by Eric Langer
Outsourcing Insights by Jim Miller
Perspectives on Outsourcing
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
April 10, 2014
Merck Announes Management Changes
April 7, 2014
Author Guidelines

Click here